Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial
Titel:
Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial
Auteur:
Oda, Yoshiaki Kumagai, Yuji Kanai, Manabu Iwama, Yasuhiro Okura, Iori Minamida, Takeshi Yagi, Yukihiro Kurosawa, Toru Greener, Benjamin Zhang, Ye Walson, Judd L